lansoprazole has been researched along with Acute Kidney Tubular Necrosis in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, L | 1 |
| Pang, W | 1 |
| Huang, Y | 1 |
| Wu, H | 1 |
| Huang, X | 1 |
| Liu, J | 1 |
| Wang, S | 1 |
| Yang, C | 1 |
| Pan, Q | 1 |
| Liu, H | 1 |
1 other study available for lansoprazole and Acute Kidney Tubular Necrosis
| Article | Year |
|---|---|
Lansoprazole promotes cisplatin-induced acute kidney injury via enhancing tubular necroptosis.
Topics: Acute Kidney Injury; Animals; Antineoplastic Agents; Apoptosis; Cisplatin; Disease Models, Animal; D | 2021 |